Bath & Body Works Zukünftiges Wachstum
Future Kriterienprüfungen 0/6
Für Bath & Body Works wird ein Gewinn- und Umsatzwachstum von 2.8% bzw. 1.6% pro Jahr prognostiziert, während der Gewinn je Aktie voraussichtlich um 5.5% pro Jahr steigen soll.
Wichtige Informationen
2.8%
Wachstumsrate der Gewinne
5.51%
EPS-Wachstumsrate
| Specialty Retail Gewinnwachstum | 9.8% |
| Wachstumsrate der Einnahmen | 1.6% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 23 Jun 2026 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Narrativ-Update • Jun 16
BBWI: Turnaround Execution In Core Categories Will Drive Future Upside
Analysts have trimmed their fair value estimate for Bath & Body Works, reducing the implied price target from about $44.60 to roughly $42.15 as they balance cautious views on category pressures and macro risks against expectations for steadier revenue growth, slightly higher profit margins, and a modestly lower discount rate and future P/E multiple. Analyst Commentary Recent Street research on Bath & Body Works stock shows a mixed but generally constructive tone, with most firms recalibrating price targets while still highlighting cost savings, brand strength, and a multi year turnaround plan as key factors to watch.Analyseartikel • Jun 09
We Think You Can Look Beyond Bath & Body Works' (NYSE:BBWI) Lackluster Earnings
The market was pleased with the recent earnings report from Bath & Body Works, Inc. ( NYSE:BBWI ), despite the profit...
Narrativ-Update • Jun 02
BBWI: Turnaround Efforts And Cost Controls Will Likely Offset Macro Pressures
Analysts have trimmed the Bath & Body Works fair value estimate from $22.00 to $19.00. This reflects a series of lower Street price targets around $19 to $23, as they balance concerns about ongoing category pressure, macro and inflation headwinds, and execution risk against early signs of cost control and the company's longer term turnaround efforts.Analyseartikel • May 29
Bath & Body Works, Inc. Just Beat EPS By 215%: Here's What Analysts Think Will Happen Next
Shareholders of Bath & Body Works, Inc. ( NYSE:BBWI ) will be pleased this week, given that the stock price is up 18...Seeking Alpha • May 27
Bath & Body Works Q1 Recap: Clean Quarter, Shares Fairly Valued
Summary Bath & Body Works, Inc. just reported its Q1, and the results came in ahead of expectations. The struggling personal-care retailer is in the midst of an operational turnaround in an effort to return the business to growth. Today’s BBWI results show progress, though there is clearly still a journey ahead. While BBWI shares appear to be a value at around 7x forward earnings, I see the stock as appropriately priced at current levels. Read the full article on Seeking AlphaNarrativ-Update • May 11
BBWI: Amazon Storefront And Turnaround Plan Will Likely Drive Future Upside
Analysts have nudged their average price targets for Bath & Body Works higher into the low to mid $20s, citing Q4 results that were better than expected for several firms, updated models, and management's refreshed business strategy, while still highlighting ongoing pressure on sales trends and margins into 2026. Analyst Commentary Across recent research, most firms adjusted their models for Bath & Body Works following Q4 results and the updated business strategy.
Narrativ-Update • Apr 27
BBWI: Amazon Launch And Turnaround Plan Will Support Post 2026 Margin Recovery
Narrative Update: Bath & Body Works Analysts have modestly lifted the average price target for Bath & Body Works to about $25 to $26. This reflects Q4 results that were better than expected, alongside mixed views on ongoing margin pressure, turnaround efforts, and the updated long term growth strategy.Narrativ-Update • Apr 13
BBWI: Core Product Reset And Amazon Launch Will Support Post 2026 Margin Recovery
Narrative Update The updated analyst framework lifts the illustrative price target for Bath & Body Works by about $3 per share to roughly $28. Analysts cite better than expected Q4 performance, refreshed long term business plans, model updates following recent results, and an expectation for some P/E multiple expansion, even as they highlight ongoing topline and margin pressures and mixed views on the core business.
Narrativ-Update • Mar 31
BBWI VALUATION
julio has decreased revenue growth from 5.7% to 3.2% and decreased future PE multiple from 12.0x to 8.0x.Narrativ-Update • Mar 30
BBWI: Amazon Launch And Turnaround Execution Will Likely Drive Future Upside
Bath & Body Works' analyst fair value estimate has increased from $17.00 to $22.00 following better than expected Q4 results, updated models, and a shift in business strategy that supports higher future P/E assumptions, despite ongoing pressure on margins and topline expectations. Analyst Commentary Recent research on Bath & Body Works points to a more nuanced setup, with several firms lifting price targets after Q4 yet keeping a relatively restrained stance on ratings and longer term growth expectations.
Neues Narrativ • Mar 16
Bath & Body Works is a dominant, high-quality consumer brand with near-perfect business economics, temporarily depressed by a demand trough
Most investors look at BBWI and see a mall candle retailer. That framing undersells it significantly.Narrativ-Update • Mar 16
BBWI: Turnaround Execution And Amazon Rollout Will Drive Future Upside
Analysts have trimmed the Bath & Body Works fair value estimate to about $44.60, even as several Street price targets now cluster in the low to high $20s. This reflects updated views on slower revenue growth, slightly softer margins, a higher discount rate, and a lower assumed future P/E multiple.Narrativ-Update • Mar 02
BBWI: Weak Core And Amazon Expansion Will Likely Restrain Future Upside
Narrative Update: Bath & Body Works Analysts have inched their average price target for Bath & Body Works higher by $1 to $22. This reflects a view that recent target increases, balanced upside and downside into Q4 earnings, and ongoing concerns about a weaker core business and the need for more investment leave the risk and reward relatively even at current levels.Narrativ-Update • Feb 16
BBWI: Earnings Reset And Legal Headwinds Will Likely Cap Near Term Upside
Narrative Update The updated analyst price target for Bath & Body Works shifts toward the mid to high teens, around $17 to $21. Analysts generally point to mixed recent earnings, reset expectations for sales and margins into 2026, and a more cautious stance on revenue trends and valuation multiples.Narrativ-Update • Feb 02
BBWI: Core Product Refocus And Digital Reset Will Support Post 2026 Margin Recovery
Analysts have inched up their Bath & Body Works fair value estimate to about $24.62 per share, reflecting slightly higher assumed revenue growth and P/E multiples, partly tempered by softer margin expectations and a series of cautious Hold and Neutral ratings following recent earnings and guidance resets. Analyst Commentary Recent Street research on Bath & Body Works has clustered around Hold, Neutral, Equal Weight, and Market Perform ratings, with several firms cutting price targets following the latest Q3 miss and Q4 guidance reset.Narrativ-Update • Jan 19
BBWI: Earnings Reset And Margin Pressure Will Likely Cap Near Term Upside
Analysts have cut their fair value estimate for Bath & Body Works from US$32 to US$17, reflecting softer revenue and margin expectations, a higher discount rate, and a reset in forward P/E assumptions following Q3 earnings misses, cautious Q4 guidance, and a series of price target reductions and downgrades across the Street. Analyst Commentary Recent Street research on Bath & Body Works has shifted toward a more cautious stance, with several firms resetting ratings and price targets following the Q3 earnings miss and weaker Q4 outlook.Narrativ-Update • Jan 05
BBWI: Digital And Distribution Improvements Will Support Post 2026 Margin Recovery
Bath & Body Works' analyst price targets have moved sharply lower into a roughly mid to high teens US$ range, as analysts respond to Q3 earnings misses, reduced Q4 guidance, softer sales trends and weaker margins that have led to a series of downgrades and concerns about near term revenue and margin visibility. Analyst Commentary Recent research updates show a clear reset in expectations for Bath & Body Works, with price targets clustered in the mid to high teens and ratings generally moved to Neutral or equivalent.Analyseartikel • Dec 21
Bath & Body Works, Inc. (NYSE:BBWI) Stock Catapults 33% Though Its Price And Business Still Lag The Market
Bath & Body Works, Inc. ( NYSE:BBWI ) shareholders are no doubt pleased to see that the share price has bounced 33% in...Narrativ-Update • Dec 18
BBWI: Digital And Distribution Improvements Will Support Margin Recovery After 2026 Reset
Analysts have modestly reduced our Bath & Body Works fair value estimate, despite a small uptick in modeled revenue growth and profit margin and a slightly higher future P E multiple. This reflects a broad reset in Street price targets to the mid to high teens after disappointing Q3 results, weaker guidance, and expectations that meaningful topline and margin recovery will not materialize until 2026.Narrativ-Update • Dec 04
BBWI: Digital And Distribution Improvements Will Drive Stronger Margins After 2026 Reset
Analysts have sharply reduced their price target on Bath & Body Works, cutting fair value from approximately $37 to about $24 as they factor in weaker near term revenue growth, modest margin pressure, and lower future earnings multiples amid broad downgrades and reset expectations through 2026. Analyst Commentary Recent Street research reflects a sharp turn in sentiment on Bath & Body Works, with multiple firms cutting ratings and price targets following a disappointing Q3 print and weaker Q4 outlook.Analyseartikel • Nov 23
Earnings Miss: Bath & Body Works, Inc. Missed EPS By 5.1% And Analysts Are Revising Their Forecasts
As you might know, Bath & Body Works, Inc. ( NYSE:BBWI ) last week released its latest quarterly, and things did not...Analyseartikel • Nov 20
Bath & Body Works' (NYSE:BBWI) Dividend Will Be $0.20
Bath & Body Works, Inc.'s ( NYSE:BBWI ) investors are due to receive a payment of $0.20 per share on 5th of December...Narrativ-Update • Nov 20
BBWI: Margins Will Strengthen As Digital And Distribution Efforts Gain Traction
Analysts have lowered their average price target for Bath & Body Works by nearly $1 to approximately $37. They cite recent challenges with digital improvements, increased discounting, and limited progress in reducing promotions as key factors influencing their outlook.Narrativ-Update • Nov 05
BBWI: Sales Will Face Margin Pressure Amid Heavy Promotions
Analysts have modestly reduced their price targets for Bath & Body Works, with updated estimates reflecting a decrease of approximately $1. They now cite ongoing promotional activity and macroeconomic uncertainty as factors limiting near-term upside.Narrativ-Update • Oct 22
Analysts Cite Mixed Outlook for Bath & Body Works as Price Target Edges Lower
The analyst price target for Bath & Body Works was revised slightly downward from $39.33 to $38.83. Analysts cited continued heavy promotions, mixed results from product launches, and ongoing macroeconomic challenges that are limiting near-term sales and margin improvements.Narrativ-Update • Oct 08
Digital Transformation And Global Expansion Will Build A Robust Future
Analysts have slightly lowered their price target for Bath & Body Works, trimming the estimate from $41 to $40. Updated forecasts suggest softer revenue growth and profit margin ahead following the latest quarterly results.Narrativ-Update • Sep 04
Digital Transformation And Global Expansion Will Build A Robust Future
With consensus revenue growth and discount rate forecasts for Bath & Body Works both remaining stable, the analyst fair value target also stayed unchanged at $40.73. What's in the News Bath & Body Works revised its full-year 2025 sales growth guidance to 1.5%-2.7% (from 1%-3%) and lowered EPS expectations to $3.28–$3.53, below fiscal 2024’s $3.61.Analyseartikel • Aug 31
Bath & Body Works, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Last week, you might have seen that Bath & Body Works, Inc. ( NYSE:BBWI ) released its second-quarter result to the...Analyseartikel • Aug 20
Bath & Body Works (NYSE:BBWI) Has Announced A Dividend Of $0.20
Bath & Body Works, Inc.'s ( NYSE:BBWI ) investors are due to receive a payment of $0.20 per share on 5th of September...Analyseartikel • Aug 06
Bath & Body Works, Inc.'s (NYSE:BBWI) Intrinsic Value Is Potentially 53% Above Its Share Price
NYSE:BBWI 1 Year Share Price vs Fair Value Explore Bath & Body Works's Fair Values from the Community and select yours...Analyseartikel • Jul 16
Weekly Picks: 📈 MSTR's Leveraged Bitcoin Exposure, QS' Breakthrough Battery Tech, and BBWI's Turnaround Potential
📈 Why Strategy is a compelling vehicle to gain leveraged Bitcoin exposure. 💰 How debt reduction is a key driver to Bath & Body Works' success. 🔋 Why QuantumScape’s technology could solve all current EV problems.Neues Narrativ • Jul 15
Emerging Markets and Debt Reduction Will Propel Bath & Body Works Forward
Bath and Body Works is an interesting company to try and project for since it has so many irregular attributes that make it trickier to predict future growth because of. The biggest reason it becomesAnalyseartikel • Jul 09
Bath & Body Works, Inc. (NYSE:BBWI) Stock Catapults 26% Though Its Price And Business Still Lag The Market
Bath & Body Works, Inc. ( NYSE:BBWI ) shares have had a really impressive month, gaining 26% after a shaky period...Analyseartikel • May 19
Bath & Body Works' (NYSE:BBWI) Dividend Will Be $0.20
The board of Bath & Body Works, Inc. ( NYSE:BBWI ) has announced that it will pay a dividend on the 20th of June, with...Analyseartikel • May 09
Earnings Working Against Bath & Body Works, Inc.'s (NYSE:BBWI) Share Price
Bath & Body Works, Inc.'s ( NYSE:BBWI ) price-to-earnings (or "P/E") ratio of 8.5x might make it look like a strong buy...Seeking Alpha • Apr 14
Bath & Body Works: Debt Is One Of Two Good Income Options
Summary Bath & Body Works faces industry challenges and trade war impacts but offers attractive income options through its long-term debt and put options. Despite sales declines, the company maintains a healthy gross profit margin and has improved its equity position by reducing long-term debt. Operating cash flow remains strong, supporting dividends, debt repayment, and stock repurchases, with stable free cash flow since the pandemic. Conservative investors can benefit from the company's 7.4% yielding bonds, while higher risk-tolerant investors might consider short-term put options for income. Read the full article on Seeking AlphaSeeking Alpha • Apr 09
Bath & Body Works: Rating Downgrade On Macro Turmoil And Potential EPS Miss
Summary I downgraded Bath & Body Works Inc. from hold to sell, due to macroeconomic turmoil and potential EPS guidance misses. Recent tariffs and macro developments threaten BBWI's turnaround, impacting consumer spending and increasing reliance on promotions, which could hurt margins. Inventory levels are rising, suggesting the potential for aggressive discounting, further pressuring earnings and merchandise margins. Valuation concerns arise as consensus estimates haven't priced in new tariffs, risking BBWI missing estimates and leading to further stock de-rating. Read the full article on Seeking AlphaSeeking Alpha • Mar 04
Bath & Body Works: Undervalued Despite Materializing Tariff Headwind
Summary Bath & Body Works, Inc. ended FY2024 on a strong note as earnings performed stably comparably. The FY2025 outlook stands worse than expected. Further, Trump's 25% tariffs on Canada & Mexico, and an additional 10% tariff on China could have a negative impact on earnings. Supply chain management could mitigate some of the negative impacts, and Bath & Body Works' high margins should still enable quite stable earnings despite the headwind. I still estimate BBWI stock to be undervalued with a 43% upside to a fair value of $47.6. Read the full article on Seeking AlphaGewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 1/31/2029 | 7,530 | 669 | N/A | N/A | 5 |
| 1/31/2028 | 7,240 | 577 | 552 | 797 | 15 |
| 1/31/2027 | 7,102 | 593 | 618 | 860 | 15 |
| 5/2/2026 | 7,245 | 727 | 909 | 1,158 | N/A |
| 1/31/2026 | 7,291 | 649 | 865 | 1,102 | N/A |
| 11/1/2025 | 7,354 | 699 | 946 | 1,180 | N/A |
| 8/2/2025 | 7,371 | 728 | 783 | 1,001 | N/A |
| 5/3/2025 | 7,347 | 816 | 781 | 998 | N/A |
| 2/1/2025 | 7,307 | 798 | 660 | 886 | N/A |
| 11/2/2024 | 7,432 | 924 | 643 | 857 | N/A |
| 8/3/2024 | 7,384 | 937 | 686 | 907 | N/A |
| 5/4/2024 | 7,417 | 884 | 735 | 986 | N/A |
| 2/3/2024 | 7,429 | 878 | 656 | 954 | N/A |
| 10/28/2023 | 7,405 | 727 | 779 | 1,105 | N/A |
| 7/29/2023 | 7,448 | 699 | 795 | 1,140 | N/A |
| 4/29/2023 | 7,506 | 720 | 789 | 1,122 | N/A |
| 1/28/2023 | 7,560 | 794 | 816 | 1,144 | N/A |
| 10/29/2022 | 7,700 | 958 | 831 | 1,112 | N/A |
| 7/30/2022 | 7,776 | 1,044 | 747 | 1,000 | N/A |
| 4/30/2022 | 7,862 | 1,139 | 1,016 | 1,309 | N/A |
| 1/29/2022 | 7,882 | 1,075 | 1,222 | 1,492 | N/A |
| 10/30/2021 | 7,572 | 1,040 | 1,511 | 1,780 | N/A |
| 7/31/2021 | 7,593 | 1,059 | 2,044 | 2,326 | N/A |
| 5/1/2021 | 6,250 | 1,253 | 2,392 | 2,630 | N/A |
| 1/30/2021 | 6,434 | 865 | 1,811 | 2,039 | N/A |
| 10/31/2020 | 8,423 | 116 | 1,766 | 2,032 | N/A |
| 8/1/2020 | 9,398 | -332 | 1,022 | 1,360 | N/A |
| 5/2/2020 | 11,939 | -703 | 577 | 967 | N/A |
| 2/1/2020 | 5,405 | 460 | N/A | 1,236 | N/A |
| 11/2/2019 | 13,059 | 366 | N/A | 1,274 | N/A |
| 8/3/2019 | 13,157 | 575 | N/A | 1,327 | N/A |
| 5/4/2019 | 13,240 | 636 | N/A | 1,383 | N/A |
| 2/2/2019 | 13,237 | 644 | N/A | 1,377 | N/A |
| 11/3/2018 | 13,208 | 768 | N/A | 1,281 | N/A |
| 8/4/2018 | 13,050 | 897 | N/A | 1,397 | N/A |
| 5/5/2018 | 12,821 | 937 | N/A | 1,320 | N/A |
| 2/3/2018 | 12,632 | 983 | N/A | 1,406 | N/A |
| 10/28/2017 | 12,298 | 951 | N/A | 1,717 | N/A |
| 7/29/2017 | 12,262 | 986 | N/A | 1,703 | N/A |
| 4/29/2017 | 12,397 | 1,100 | N/A | 2,040 | N/A |
| 1/28/2017 | 12,574 | 1,158 | N/A | 1,990 | N/A |
| 10/29/2016 | 12,480 | 1,162 | N/A | 2,018 | N/A |
| 7/30/2016 | 12,381 | 1,205 | N/A | 2,002 | N/A |
| 4/30/2016 | 12,256 | 1,155 | N/A | 1,982 | N/A |
| 1/30/2016 | 12,154 | 1,253 | N/A | 2,027 | N/A |
| 10/31/2015 | 11,828 | 1,182 | N/A | 1,678 | N/A |
| 8/1/2015 | 11,665 | 1,150 | N/A | 1,715 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: BBWIDas prognostizierte Gewinnwachstum (2.8% pro Jahr) liegt unter der Sparquote (3.5%).
Ertrag vs. Markt: BBWIDie Erträge des Unternehmens (2.8% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (18.4% pro Jahr).
Hohe Wachstumserträge: BBWIDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: BBWIDie Einnahmen des Unternehmens (1.6% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (12.7% pro Jahr).
Hohe Wachstumseinnahmen: BBWIDie Einnahmen des Unternehmens (1.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von BBWI in 3 Jahren voraussichtlich hoch sein wird
Wachstumsunternehmen entdecken
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/06/25 06:30 |
| Aktienkurs zum Tagesende | 2026/06/25 00:00 |
| Gewinne | 2026/05/02 |
| Jährliche Einnahmen | 2026/01/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Details des Analysemodells, das zur Erstellung dieses Berichts verwendet wurde, sind auf unserer GitHub-Seite verfügbar. Außerdem haben wir Leitfäden zur Nutzung unserer Berichte und Tutorials auf YouTube.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
Bath & Body Works, Inc. wird von 40 Analysten beobachtet. 15 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| null null | Argus Research Company |
| Mark Altschwager | Baird |
| Matthew McClintock | Barclays |